Psilocybin breaks rigid patterns in the depressed brain, study shows

psilocybin-breaks-rigid-patterns-in-the-depressed-brain,-study-shows

Psilocybin, the active compound in magic mushrooms, can ‘open up’ the brains of people with depression, helping patients to overcome rigid thought patterns and negative fixations, new research suggests. A study led by the Imperial Centre for Psychedelic Research has shown that psilocybin therapy increases brain connectivity in people living with depression, even weeks after…

CBD pill found to be effective alternative to opioids when treating shoulder pain

cbd-pill-found-to-be-effective-alternative-to-opioids-when-treating-shoulder-pain

America is currently living through an opioid epidemic that has had deadly consequences for its communities for decades. 2020 was the deadliest on record with over 75,000 overdoses directly related to opioids. Many observers agree this crisis was born in the early 1990s and was exacerbated in 1995 by the licensing and the mass marketing…

Ketamine could be used safely in the treatment of Parkinson’s disease, study finds

ketamine-could-be-used-safely-in-the-treatment-of-parkinson’s-disease,-study-finds

Low-dose ketamine infusion appears to be effective at reducing levodopa-induced dyskinesia (LID) in patients with Parkinson’s disease. Topline results from a Phase 2 study conducted by PharmaTher, a leading company in speciality ketamine pharmaceuticals, show that 100% of patients treated with ketamine experienced a reduction in dyskinesias, with no serious side effects.   The study aimed…

MDMA assisted therapy significantly reduces eating disorder symptoms

mdma-assisted-therapy-significantly-reduces-eating-disorder-symptoms

Researchers have published a study that shows MDMA assisted therapy (MDMA-AT) produces positive results for patients living with eating disorders and Post Traumatic Stress Disorder (PTSD). It is estimated that globally 8.4% of women and 2.2% of men live with an eating disorder, in the UK the total figure is estimated to be 1.4 million. …

People who live with Tourette syndrome experience a reduction in tics when using cannabis

people-who-live-with-tourette-syndrome-experience-a-reduction-in-tics-when-using-cannabis

Scientists in Tel Aviv, Israel have released the results of a small study into the viability of treating Tourette syndrome with cannabis. The open-label clinical trial was to determine the effectiveness and tolerability of medicinal cannabis treatment on adult patients who live with Gilles de la Tourette syndrome (GTS). GTS is a childhood-onset neuropsychiatric disorder…

Rise in European cannabis and other drug use detected in EMCDDA study

rise-in-european-cannabis-and-other-drug-use-detected-in-emcdda-study

The Lisbon based European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has published a report which reveals levels of drug consumption across Europe. Data was gathered by testing wastewater for illegal drugs in around 80 cities across 23 countries. The authors of the report say it provides a valuable snapshot of the drug flow…

People who smoke cannabis may be at risk of ageing faster, study warns

people-who-smoke-cannabis-may-be-at-risk-of-ageing-faster,-study-warns

Scientists have published findings of 17 year long study that appears to show smoking cannabis, even without tobacco, can result in a higher epigenetic age.  Our epigenetic age differs from our birth age and is believed to be influenced by external factors. These external factors can result in a difference between our birth age and…